Multiple Myeloma Waldenström macroglobulinemia MGUS MGRS Plasma Cell Dyscrasias Introduction

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=GaCyl7TPzOg

Paul Richardson, MD, from the Dana-Farber Cancer Institute, Boston, MA, discusses the use of daratumumab in the treatment of multiple myeloma at the 2017 Bri...

treatment, antibody, monoclonal antibody, relapsed and refractory, progression free survival, NCT02076009, NCT02136134, Subject: Multiple Myeloma, Medicines: Bortezomib, Medicines: Daratumumab, Medicines: Dexamethasone, Medicines: Elotuzumab, Medicines: Lenalidomide, Trial: CASTOR, Trial: POLLUX, Speaker: Paul Richardson, Event: BSH 2017, Format: Interview, Medicines: Antibodies, Field: Immuno-Oncology
#############################